Work

Weighing options: empiric antibiotic use and stewardship opportunities in critically ill patients with community-acquired pneumonia

Year: 2025

Type: article

Abstract: In this retrospective study, critically ill patients with community-acquired pneumonia frequently received empiric anti-methicillin-resistant Staphylococcus aureus (MRSA) and antipseudomonal antibiotics despite having few or no guidelines-endorsed risk factors. De-escalation of anti-MRSA therapy was quicker, likely aided by MRSA polymerase chain reaction assays.

Source: Antimicrobial Stewardship & Healthcare Epidemiology

DOI: 10.1017/ash.2025.10082

Authors: Nalea Trujillo, Calvin Diep, David Ha, Ariadna Garcia, Marisa Holubar

Institutions: Stanford Health Care, Stanford University, Stanford Medicine

Language: English

Topic: Antibiotic Use and Resistance

Subfield: Applied Microbiology and Biotechnology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,719